Научно-Исследовательский Институт Реабилитации Инвалидов (Учебно-Научно-Лечебный Комплекс) Винницкого Национального Медицинского Университета Им. Н.И. Пирогова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Научно-Исследовательский Институт Реабилитации Инвалидов (Учебно-Научно-Лечебный Комплекс) Винницкого Национального Медицинского Университета Им. Н.И. ПироговаfiledCriticalНаучно-Исследовательский Институт Реабилитации Инвалидов (Учебно-Научно-Лечебный Комплекс) Винницкого Национального Медицинского Университета Им. Н.И. Пирогова
Priority to UAU201314733UpriorityCriticalpatent/UA89746U/en
Publication of UA89746UpublicationCriticalpatent/UA89746U/en
108090000623proteins and genesProteins0.000abstract1
Landscapes
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The method for treating osteoporosis in the patients with systemic lupus erythematosus comprises X-ray imaging, the detection of mutation-1 of nitrogen oxide synthase gene and the mutation of methylene tetrahydrofolate reductase gene. In the case of the combination of the pathologic homozygotes 786-CC and 677TT, Tivortin, Decamevit, and Osteogenon are provided in several treatment courses until osteoporosis elimination.
UAU201314733U2013-12-162013-12-16Method for treating osteoporosis in patients with systemic lupus erythematosus
UA89746U
(en)